IgNS Home

Reimagine What's Possible

Explore

See if TAKHZYRO may be right for your patients.

Takeda Offers the Broadest Range of IG Therapies and Resources1

1. Marketing Research Bureau. The plasma proteins market in the United States—2018. Revised 2019:1-298.

Please click for Full Prescribing Information, including BOXED WARNINGS for CUVITRU, HYQVIA, GAMMAGARD LIQUID, and GAMMAGARD S/D.

Medical Affairs
Takeda

This site is intended for US residents and governed by US laws and government regulations. Please see our online Privacy Policy for more information. ©2023 Takeda Pharmaceuticals U.S.A., Inc. Lexington, MA 02421.
1-877-TAKEDA-7 (1-877-825-3327). All rights reserved. TAKHZYRO is a trademark or registered trademark of Dyax Corp., a Takeda company. FIRAZYR and OnePath are trademarks or registered trademarks of Shire, a Takeda company. CUVITRU, HYQVIA, GAMMAGARD LIQUID, GAMMAGARD S/D and MYIGSOURCE are trademarks or registered trademarks of Baxalta Incorporated, a Takeda company. Takeda and the Takeda logo are trademarks or registered trademarks of Takeda Pharmaceutical Company Limited.

US-XMP-0492v8.0   04/23

For US Healthcare Professionals Only

The information on this website has been specifically created for US healthcare professionals (HCPs).

Agree and continue to site

You are now leaving the Homepage and entering the Medical Affairs Area.

Yes, I want to leave